Fmoc-N-Pbf-L-HomoArginine
Fmoc-N-Pbf-L-HomoArginine 物理性質
- 比重(密度) :
- 1.35±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- Sealed in dry,Store in freezer, under -20°C
- 酸解離定数(Pka):
- 4.37±0.10(Predicted)
- 外見 :
- Solid
- 色:
- White to off-white
- 水溶解度 :
- 水にわずかに溶ける。
安全性情報
Fmoc-N-Pbf-L-HomoArginine 価格
もっと(2)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01AFAH52115 |
N^a-Fmoc-N^w-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-^b-homoarginine, 95% |
401915-53-5 |
250mg |
￥52880 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01AFAH52115 |
N^a-Fmoc-N^w-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-^b-homoarginine, 95% |
401915-53-5 |
1g |
￥82830 |
2024-03-01 |
購入 |
Fmoc-N-Pbf-L-HomoArginine 化学特性,用途語,生産方法
使用
It is used as a pharmaceutical intermediate.
Fmoc-N-Pbf-L-HomoArginine 上流と下流の製品情報
原材料
準備製品
Fmoc-N-Pbf-L-HomoArginine 生産企業
Global( 149)Suppliers
401915-53-5()キーワード:
- 401915-53-5
- (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-(3-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)guanidino)hexanoic acid
- N2-Fmoc-N6-Pbf-L-homoArginine
- N-alpha-FMoc-N-oMega-(2,2,4,6,7-pentaMethyldihydrobenzofuran-5-sulfonyl)-L-hoMoarginine
- N^a-FMoc-N^w-(2,2,4,6,7-pentaMethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-^b-hoMoarginine, 95%
- Fmoc-N-Pbf-L-HomoArginine
- N-Fmoc-N'-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sufonyl)-L-homearginine
- FMoc-D-beta-hoMoarginine(Pbf)
- FMOC-HOMO-ARG
- Fmoc-HomArg(pbf)-OH
- Hexanoic acid,6-[[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]amino]-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(3S)-
- Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-beta-homoarginine
- N-Fmoc-N'-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sufonyl)-L-homoarginine
- (2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-6-[1-(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-sulfonyl)carbamimidamido]hexanoic acid
- -[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido}hexanoic acid
- (S)-3-(Fmoc-amino)-6-[3-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)guanidino]hexanoic Acid
- Fmoc-L-HomoArg(Pbf)-OH, >97%
- (3S)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-6-{N'-[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido}hexanoic acid
- Fmoc-2-HoArg(Pbf)-OH
- Fmoc-L-b-HomoArg(Pbf)-OH
- Fmoc-β-HomoArg(Pbf)-OH
- Fmoc-L-β-Homo-Arg(Pbf)-OH
- Fmoc-N-Pbf-L-HomoArginine USP/EP/BP
- N-β-(9-Fluorenylmethoxycarbonyl)-N-ω-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)-L-β-homoarginine
- Fmoc-β-HoArg(Pbf)-OH
- FMOC-BETA-HOARG(PBF)-OH
- Hexanoic acid,6-[[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-ben...
- Nalpha-Fmoc-N^w-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-beta-homoarginine, 95%,
- Fmoc-HomoArg(Pbf)-OH
- FMoc-Harg(Pbf)-OH
- N-fluoromethoxycarbonyl-N '- (2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl) - L-homoarginine